Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial

Background In this phase I/II trial, we evaluated the safety and effectiveness of pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from metastatic non-small cell lung cancer (mNSCLC).Methods Patients with lung or liver lesions amenable to RT plus at least one a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chad Tang, Patricia de Groot, James Welsh, Hari Menon, Dawei Chen, Vivek Verma, Mehmet Altan, Kenneth Hess, John V Heymach, Quynh-Nhu Nguyen, Rejani Varghese, Nathan I Comeaux, George Simon, Ferdinandos Skoulidis, Joe Y Chang, Vasiliki Papdimitrakopoulou, Steven H Lin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2020-10-01
coleção:	Journal for ImmunoTherapy of Cancer
Acesso em linha:	https://jitc.bmj.com/content/8/2/e001001.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!